Black Diamond Therapeutics, Inc. (BDTX)
Nasdaq · Biological Products, (No Diagnostic Substances)
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
No signals recorded in the last 12 months.
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-18 | Raman Prakash | director | A | 6,801 | 1.93 | $13,126 |
| 2026-09-18 | Behbahani Ali | director | A | 7,707 | 1.93 | $14,875 |
| 2026-06-19 | Behbahani Ali | director | A | 8,961 | 1.66 | $14,875 |
| 2026-06-19 | Raman Prakash | director | A | 7,907 | 1.66 | $13,126 |
| 2026-06-19 | Behbahani Ali | director | A | 8,961 | 1.66 | $14,875 |
| 2026-06-19 | Raman Prakash | director | A | 7,907 | 1.66 | $13,126 |
| 2026-03-20 | Behbahani Ali | director | A | 6,919 | 2.15 | $14,876 |
| 2026-03-20 | Raman Prakash | director | A | 6,105 | 2.15 | $13,126 |
| 2026-03-20 | Behbahani Ali | director | A | 6,919 | 2.15 | $14,876 |
| 2026-03-20 | Raman Prakash | director | A | 6,105 | 2.15 | $13,126 |
| 2025-12-12 | Behbahani Ali | director | A | 5,208 | 2.76 | $14,374 |
| 2025-12-12 | Raman Prakash | director | A | 4,665 | 2.76 | $12,875 |
| 2025-12-12 | Behbahani Ali | director | A | 5,208 | 2.76 | $14,374 |
| 2025-12-12 | Raman Prakash | director | A | 4,665 | 2.76 | $12,875 |
| 2025-09-19 | Behbahani Ali | director | A | 4,291 | 3.35 | $14,375 |
| 2025-09-19 | Raman Prakash | director | A | 3,843 | 3.35 | $12,874 |
| 2025-09-19 | Behbahani Ali | director | A | 4,291 | 3.35 | $14,375 |
| 2025-09-19 | Raman Prakash | director | A | 3,843 | 3.35 | $12,874 |
| 2025-06-20 | Behbahani Ali | director | A | 6,170 | 2.33 | $14,376 |
| 2025-06-20 | Raman Prakash | director | A | 5,526 | 2.33 | $12,876 |
| 2025-06-20 | Behbahani Ali | director | A | 6,170 | 2.33 | $14,376 |
| 2025-06-20 | Raman Prakash | director | A | 5,526 | 2.33 | $12,876 |
| 2025-03-21 | Behbahani Ali | director | A | 7,646 | 1.88 | $14,374 |
| 2025-03-21 | Raman Prakash | director | A | 6,848 | 1.88 | $12,874 |
| 2025-03-21 | Behbahani Ali | director | A | 7,646 | 1.88 | $14,374 |
| 2025-03-21 | Raman Prakash | director | A | 6,848 | 1.88 | $12,874 |
| 2025-03-19 | BIOTECH GROWTH N V | ten percent owner | S | 400,000 | 2.09 | $836,000 |
| 2025-03-19 | BIOTECH GROWTH N V | ten percent owner | S | 500,000 | 2.12 | $1,060,000 |
| 2025-03-19 | BIOTECH GROWTH N V | ten percent owner | S | 1,000,000 | 2.07 | $2,070,000 |
| 2025-03-19 | BIOTECH GROWTH N V | ten percent owner | S | 2,000,000 | 2 | $4,000,000 |
| 2025-03-19 | BIOTECH GROWTH N V | ten percent owner | S | 1,000,000 | 2.31 | $2,310,000 |
| 2025-03-19 | BIOTECH GROWTH N V | ten percent owner | S | 300,000 | 1.94 | $582,000 |
| 2025-03-19 | BIOTECH GROWTH N V | ten percent owner | S | 584,292 | 1.95 | $1,139,369 |
| 2025-03-19 | BIOTECH GROWTH N V; BB BIOTECH AG | ten percent owner | S | 1,000,000 | 2.07 | $2,069,100 |
| 2025-03-19 | BIOTECH GROWTH N V; BB BIOTECH AG | ten percent owner | S | 300,000 | 1.94 | $582,900 |
| 2025-03-19 | BIOTECH GROWTH N V; BB BIOTECH AG | ten percent owner | S | 1,000,000 | 2.31 | $2,308,100 |
| 2025-03-19 | BIOTECH GROWTH N V; BB BIOTECH AG | ten percent owner | S | 2,000,000 | 2 | $4,000,800 |
| 2025-03-19 | BIOTECH GROWTH N V; BB BIOTECH AG | ten percent owner | S | 400,000 | 2.09 | $837,160 |
| 2025-03-19 | BIOTECH GROWTH N V; BB BIOTECH AG | ten percent owner | S | 584,292 | 1.95 | $1,141,239 |
| 2025-03-19 | BIOTECH GROWTH N V; BB BIOTECH AG | ten percent owner | S | 500,000 | 2.12 | $1,058,450 |
| 2025-01-30 | Velleca Mark A. | director | A | 75,000 | 0 | $0 |
| 2025-01-30 | Yurasov Sergey | officer | A | 75,000 | 0 | $0 |
| 2025-01-30 | Buck Elizabeth | officer | A | 75,000 | 0 | $0 |
| 2025-01-30 | Jones Erika | officer | A | 75,000 | 0 | $0 |
| 2025-01-30 | Hatzis-Schoch Brent | officer | A | 75,000 | 0 | $0 |
| 2025-01-30 | Velleca Mark A. | director | A | 75,000 | 0 | $0 |
| 2025-01-30 | Yurasov Sergey | officer | A | 75,000 | 0 | $0 |
| 2025-01-30 | Buck Elizabeth | officer | A | 75,000 | 0 | $0 |
| 2025-01-30 | Jones Erika | officer | A | 75,000 | 0 | $0 |
| 2025-01-30 | Hatzis-Schoch Brent | officer | A | 75,000 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.